Printer Friendly

Articles from M2 Pharma (December 10, 2009)

1-32 out of 32 article(s)
Title Author Type Words
AdvanDx earns FDA 510(k) clearance for 90 Minutes PNA FISH protocol for identifying staphylococcal bloodstream pathogens. 148
BIOLASE announces FDA 510(k) clearance of Waterlase MD laser system. 216
Cytokinetics and GSK to end oncology collaboration. 139
Cytokinetics, GSK agree to terminate collaboration and license agreement. 261
Dendreon appoints Hans Bishop as COO. 174
Endosense appoints Jan Egberts as board chairman, Michael Dormer as board member. 189
Entellus Medical reports first enrollment in FinESS RELIEF study. Clinical report 192
EQT remains only private equity firm to bid for Ratiopharm. 179
Forest Laboratories appoints Peter Zimetbaum to board of directors. 142
Genpact to provide Finance & Accounting services to AstraZeneca. 111
Grifols to invest EUR16.6m in serum plant construction. 117
Knopp reports positive clinical results from Phase II study of KNS-760704 in ALS. Clinical report 222
Merck commences Phase III study of Stimuvax in Asian patients with advanced NSCLC. 238
Neurocrine announces results from Tulip PETAL study of elagolix for endometriosis pain. Clinical report 274
Nexstim gets FDA nod for Navigated Brain Stimulation for non-invasive cortical mapping prior to neurosurgery. 174
Noble Age raises EUR8.5m to pursue external growth. 150
Repligen reports Phase III clinical trial results of RG1068 in pancreatic imaging. Clinical report 232
Robert Farmer joins Northwest Biotherapeutics' board of directors. 105
Roche launches new clinical laboratory system. 173
Salix announces outcome of FDA meeting on rifaximin NDA. 336
Sangart receives European orphan drug designation for MP4CO in patients with sickle cell disease. 295
Sanofi Pasteur to conduct further dengue vaccine clinical studies. Clinical report 113
Sanofi-aventis, Alopexx enter into collaboration agreement for novel human monoclonal antibody. 220
Sonova's Phonak defends hearing aid industry. 154
Sopharma may list on Warsaw bourse next year. 238
SRI International gets USD946,089 NIH grants to develop improved tomographic imaging technology. 188
Stem Cell Therapeutics gets US patent for prolactin. 123
Targacept starts Phase II study of TC-5619 in cognitive dysfunction in schizophrenia. 248
ThermoGenesis adds Craig Moore as board member. 172
TiGenix seeks to raise EUR7.5m with private placement. 104
Vertex Pharmaceuticals names Nancy Wysenski chief commercial officer. 159
YM BioSciences reports first results from anti-cancer collaboration with NRC-BRI. Financial report 479

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |